- Q: If I want to enter a patient
into one of the trials, how do I go about it?
- A: The referral form should be
completed and faxed back to the Drug Development Program. A physician
will assess the referral information to determine whether the patient
is eligible for the study. If the patient is eligible, they will be
booked in to the next convenient clinic appointment. The patient will
have to give informed consent and then have a number of screening investigations
performed to confirm eligibility. If the patient is ineligible for the
requested study, they may be entered in to an alternative study. All
studies will be run at PMH. The Consortium studies will be run at PMH,
HRCC and LRCC.
- Q: I have an idea for a study,
whom should I contact?
- A: Physicians at PMH, HRCC, LRCC
should contact their sites PI to discuss their ideas. Community
oncologists should contact the Drug Development Program contact. Most
protocols are based on responses to solicitations from NCI but NCI also
welcomes unsolicited ideas if there is a strong scientific rationale
for doing the study, the drug is available and there are no other competing
studies at NCI. The steering committee will evaluate and assess each
- Q: I have a great idea for a newsletter
article. Who do I call?
- A: Pam Degendorfer, the program
manager would be delighted to hear from you. Please contact her via
the Drug Development contact.